These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22270303)

  • 1. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
    O'Brien JM
    Obstet Gynecol; 2012 Feb; 119(2 Pt 1):384-5; author reply 385-6. PubMed ID: 22270303
    [No Abstract]   [Full Text] [Related]  

  • 2. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
    Lim AC; Schuit E; Bloemenkamp K; Bernardus RE; Duvekot JJ; Erwich JJHM; van Eyck J; Groenwold RHH; Hasaart THM; Hummel P; Kars MM; Kwee A; van Oirschot CM; van Pampus MG; Papatsonis D; Porath MM; Spaanderman ME; Willekes C; Wilpshaar J; Mol BWJ; Bruinse HW
    Obstet Gynecol; 2011 Sep; 118(3):513-520. PubMed ID: 21860279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.
    Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Thom EA; Spong CY; Varner M; Malone F; Iams JD; Mercer BM; Thorp J; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M; Anderson G;
    N Engl J Med; 2007 Aug; 357(5):454-61. PubMed ID: 17671253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH; Istwan NB; Rhea DJ; Smarkusky L; Hoffman MC; Stanziano GJ
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps.
    Stringer EM; Vladutiu CJ; Batra P; Stringer JSA; Menard MK
    Obstet Gynecol; 2016 Dec; 128(6):1397-1402. PubMed ID: 27824772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth.
    Calda P
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):540-2. PubMed ID: 19089768
    [No Abstract]   [Full Text] [Related]  

  • 7. Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
    Heyborne KD; Allshouse AA; Carey JC
    Am J Obstet Gynecol; 2015 Dec; 213(6):844.e1-6. PubMed ID: 26275354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.
    Mainiero AD; Rouse DJ; Lopes V; Hughes BL
    Obstet Gynecol; 2015 Jul; 126(1):103-8. PubMed ID: 26241262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.
    Combs CA; Garite T; Maurel K; Das A; Porto M;
    Am J Obstet Gynecol; 2011 Mar; 204(3):221.e1-8. PubMed ID: 21376161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
    Romero R; Conde-Agudelo A
    BJOG; 2015 Jan; 122(1):6-7. PubMed ID: 25280114
    [No Abstract]   [Full Text] [Related]  

  • 12. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO; Stamilio DM; Macones GA; Polsky D
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should.
    O'Brien JM
    Am J Obstet Gynecol; 2011 May; 204(5):e16-7; author reply e17. PubMed ID: 21276949
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
    Romero R; Stanczyk FZ
    Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669
    [No Abstract]   [Full Text] [Related]  

  • 17. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Preterm Labor with 17α-Hydroxyprogesterone (17OHP) Caproate: A Comparison of Adverse Drug Reaction Rates between Compounded and Commercial Formulations.
    Stone RH; Bobowski C; Milikhiker N; Anguiano RH; Mastrogiannis D
    Am J Perinatol; 2017 Dec; 34(14):1436-1441. PubMed ID: 28704849
    [No Abstract]   [Full Text] [Related]  

  • 19. 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.
    Combs CA; Schuit E; Caritis SN; Lim AC; Garite TJ; Maurel K; Rouse D; Thom E; Tita AT; Mol B;
    BJOG; 2016 Apr; 123(5):682-90. PubMed ID: 26663620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.